'My mind pretty much went to mush': A qualitative exploration of trenbolone in the performance and image enhancing drug community.

Users should be cognisant of the potential for significant harms and health-care providers working with this group may consider more focused screening strategies. Future policy decisions regarding AAS may wish to consider the pivotal role trenbolone plays in adverse outcomes for this unique group of substance users.